Athanase Innovation AB Cash Flow-to-Debt Ratio
Athanase Innovation AB cash flow-to-debt ratio. Athanase Innovation AB (ATIN) has a Cash Flow-to-Debt Ratio of -0.47x as of June 2026, meaning its operating cash flow of Skr-31.25 Million could theoretically repay 0% of its total liabilities (Skr66.61 Million) in one year. Check Athanase Innovation AB (ATIN) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Athanase Innovation AB (2018–2026)
Cash flow-to-debt ratio of Athanase Innovation AB from 2018 to 2026. Historical debt coverage capacity for Athanase Innovation AB across 9 annual periods. Check Athanase Innovation AB (ATIN) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Athanase Innovation AB Cash Flow-to-Debt Ratio by Year (2018–2026)
Athanase Innovation AB cash flow-to-debt ratio by year from 2018 to 2026. Year-by-year debt coverage analysis for Athanase Innovation AB. For the full cash flow conversion analysis, see Athanase Innovation AB cash conversion from operations.
| Year | CF-to-Debt Ratio | Operating CF (SEK) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2026 | -1.22x | Skr-65.63 Million | Skr53.90 Million | ▼ -447.1% |
| 2025 | -0.22x | Skr-14.96 Million | Skr67.20 Million | ▲ +86.9% |
| 2024 | -1.70x | Skr-83.40 Million | Skr49.09 Million | ▼ -37.6% |
| 2023 | -1.23x | Skr-43.65 Million | Skr35.36 Million | ▲ +6.3% |
| 2022 | -1.32x | Skr-14.89 Million | Skr11.30 Million | ▼ -100.8% |
| 2021 | 159.31x | Skr23.10 Million | Skr145.00K | ▲ +308577.7% |
| 2020 | 0.05x | Skr22.34 Million | Skr432.85 Million | ▼ -21.0% |
| 2019 | 0.07x | Skr28.38 Million | Skr434.40 Million | ▲ +88.5% |
| 2018 | 0.03x | Skr15.05 Million | Skr434.42 Million | — |